The German Federal Cartel Office imposes a fine on associations of pharmacists and pharmaceutical manufacturers for organising and accomplishing a lecture series intended to convince pharmacists to refrain from price competition (Arzneimittelhersteller)

KEYWORDS
Reference

Federal Cartel Office (Bundeskartellamt), 21 December 2007, Case n° B 3 - 6/05, Arzneimittelhersteller

On 21 December 2007, the German Federal Cartel Office (FCO) imposed a fine on nine state associations of pharmacists, five pharmaceutical companies and the Federal Association of Pharmaceutical Manufacturers for organising and accomplishing a lecture series intended to convince pharmacists to refrain from price competition concerning OTC medicines and instead to adhere to the Recommended Retail Prices of the pharmaceutical manufacturers [1]. Background Over-the-counter medicines (OTC medicines) are pharmacy-only medicines which are available without prescription. Until the end of 2003, according to the Pharmaceutical Price Regulation (Arzneimittelpreisverordnung - AMPreisV) there was a national standard pharmaceutical market price for OTC medicines

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Petra Linsmeier, Moritz Lichtenegger, The German Federal Cartel Office imposes a fine on associations of pharmacists and pharmaceutical manufacturers for organising and accomplishing a lecture series intended to convince pharmacists to refrain from price competition (Arzneimittelhersteller), 21 December 2007, e-Competitions December 2007, Art. N° 21243

Visites 2406

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues